Diversity in Pharma
Who and where are the role models in the pharmaceutical industry for people of color trying to make it in the industry? I think it would be a great idea to seek out these professionals and have them tell their stories.
What’s Your Pharma Blogger Dream Team?
Bloggers operating in the Pharma BlogosphereTM are now sought after as speakers and panelists at industry meetings. Last week, I and several other bloggers...
Another Award for Rozerem! This one…not so good.
Consumers International (CI), which claims to be the only independent global campaigning voice for consumers, yesterday accused Takeda Pharmaceuticals -- marketer of the sleep...
Awards. What Are They Good For?
Awards, huh, yeah!What are they good for?Absolutely nothingUh-huhListen to meOhhh, awards, I despiseBecause it means gala dinnersOf rubber chicken and butter knivesAwards mean tearsTo...
J&J Blog, Shire PR: The Whole Story and Nothing But the Whole Story!
Wednesday was another day spent at the ExL Digital Pharma conference in Princeton, NJ -- and it was a day well spent!I caught up...
Rozerem Expedites Experts’ Dreams: Honoraria!
According to Daniel Carlat, MD, author of the The Carlat Psychiatry Report and the Carlat Psychiatry Blog, Takeda -- the folks that brought us...
Awards: POE vs. MM&M. I Pick Winners!
DTC Perspectives, a pharmaceutical industry trade publication that focuses entirely on consumer marketing, announced the winners of its sixth annual Perspectives On Excellence Awards...
9th Annual Guidelines for Disseminating Off-Label Information
Balance Scientific Discussion with Promotion in an Environment of Increased Regulatory Scrutiny
A Milestone: The Five Hundredth Post! Thank You!
Today marks a milestone for Pharma Marketing Blog: the five hundredth -- more or less -- post (#500 is "Pharma Grapples with Barriers to...
Pharma Grapples with Barriers to Adopting Web 2.0
Yesterday, I sat in at several presentations made at ExL's Digital Pharma conference in Princeton, NJ. Underlying practically every presentation and in my discussions...








